ASMQ: The development of a co-formulation: from the blueprint to the blue pill.

Abstract

This presentation describes the development of the fixed-dose antimalarial formulation ASMQ (artesunate-mefloquine), including information on the components of the tablets, packaging and chemical stability. [Some slides are in Portuguese and some in English].

Citation

Presentatation from: Scientific Symposium "Implementation of Artemisinin Combination Therapies (ACTs): Role of ASMQ". Rio de Janeiro, Brazil, 17 April 2008.

ASMQ: The development of a co-formulation: from the blueprint to the blue pill.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.